Cookson Peirce & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-11,360
| Closed | -$726K | – | 208 |
|
|
2023
Q2 | $726K | Sell |
11,360
-111,244
| -91% | -$7.11M | 0.04% | 117 |
|
|
2023
Q1 | $8.5M | Buy |
122,604
+1,147
| +0.9% | +$79.5K | 0.54% | 64 |
|
|
2022
Q4 | $8.74M | Buy |
121,457
+101,616
| +512% | +$7.31M | 0.57% | 55 |
|
|
2022
Q3 | $1.41M | Buy |
19,841
+1,334
| +7% | +$94.8K | 0.1% | 92 |
|
|
2022
Q2 | $1.43M | Buy |
18,507
+11,743
| +174% | +$904K | 0.1% | 92 |
|
|
2022
Q1 | $494K | Buy |
+6,764
| New | +$494K | 0.03% | 143 |
|
|
2014
Q2 | – | Sell |
-8,750
| Closed | -$455K | – | 137 |
|
|
2014
Q1 | $455K | Buy |
8,750
+270
| +3% | +$14K | 0.11% | 111 |
|
|
2013
Q4 | $451K | Buy |
8,480
+410
| +5% | +$21.8K | 0.12% | 101 |
|
|
2013
Q3 | $374K | Buy |
8,070
+3,320
| +70% | +$154K | 0.1% | 88 |
|
|
2013
Q2 | $213K | Buy |
+4,750
| New | +$213K | 0.06% | 89 |
|